Clinical trial
The Effect of Innovative TRPM8 Activators Membrane-Based Delivery System on Peripheral Neuropathy
NCT07583797 is registered in ClinicalTrials.gov with SHIANG-SUO HUANG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Innovative TRPM8 Activators Membrane-Based Delivery System on Peripheral Neuropathy
- Lead sponsor
- SHIANG-SUO HUANG
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- November 3, 2025
- Completion date
- June 1, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cipn - chemotherapy-induced peripheral neuropathy, diabetic peripheral neuropathy (dpn)